CCL

Carnival Corp

Stocks

The Best Stocks to Buy Before the Next Round of Stimulus

Stocks were at their lows for the year back in March when COVID-19 was spreading rapidly throughout the world for the first time.

It was a time of fear and panic in the financial markets as stocks fell about 35% from their all-time highs in February with little information to go on for the novel virus.

But then, the United States federal government went into their economic playbook and passed the Coronavirus Aid, Relief, and Economic Security (CARES) Act.

This provided over $2 trillion in economic support to American workers, families, and small businesses.

In general, most of the stock market has reacted favorably.

Since the CARES Act was passed on March 27, the S&P 500 is up 30% to new all-time highs.

So today, we're going to reveal some of the best stimulus stocks to buy now (and avoid) before a second major round of stimulus hits the markets...

Trading Strategies

The Profitable Move to Make as We Wait Around for Stimulus

The market's big struggle right now, its driving narrative, is between COVID-19 and the prospects of a new, multitrillion-dollar round of stimulus.

Stocks have rebounded over the past two days, after an apparent improvement in the president's COVID-19 symptoms merited his discharge from Walter Reed National Military Medical Center.

On the coronavirus front, investors seem to have digested the bigger picture: The virus remains a severe threat and a major disruptor, but death rates are declining right now, better therapeutics are available, and several vaccine candidates are on the horizon.

Against this backdrop, we've seen no convincing signs of progress in House Speaker Nancy Pelosi's and Treasury Secretary Steven Mnuchin's negotiations over a fresh multitrillion-dollar round of stimulus. The rally lost some significant "steam" on Tuesday after U.S. Federal Reserve Chair Jerome Powell and Speaker Pelosi stressed the need for fresh stimulus, then began a much steeper dive minutes after Trump said negotiations were off until after the November election.

White House-watchers and Wall Street insiders opined that Trump's abrupt move was likely a negotiating tactic, not the end of the stimulus road.

That's established the pattern investors will have to contend with: pullbacks, driven by stimulus worries, will be promptly followed by rallies, as coronavirus fears ease. Rinse and repeat, until further notice.

I'll tell you what I think of our stimulus chances, where the market will go next, and most importantly, the one profitable play you can make right now… Full Story

I'll tell you what I think of our stimulus chances, where the market will go next, and most importantly, the one profitable play you can make right now...

Options

The 6 Biggest Options Trading Mistakes to Avoid

Many beginning investors focus on what they need to do to find success.

And that is perfectly normal.

After all, you need to select the right stock, the right option, and then buy it at the right price.

But knowing when to sell is only have the formula.

There are also important things to avoid in this process.

Today, we're going to talk about the 6 biggest options trading mistakes you could make starting out.

Read more...

stocks

Markets Live Recap: Why the "Fed Effect" Is Very Real

Markets were volatile today as the Dow struggled to rally for the fourth day in a row, ultimately falling short.

But our experts are unfazed.

The Fed's latest push is giving this market real momentum, and it's fueling moneymaking opportunities left and right.

We've got 10 trading opportunities laid out for you below.

Chris Johnson and Andrew Keene unveiled these opportunities live today as they were tracking markets in real time.

Here's what our experts – Chris Johnson and Andrew Keene – thought about today's markets, and make sure to tune in to Markets Live tomorrow for even more actionable insight.

Read more...

stocks

Markets Live Recap: Record Retail Sales Push Stocks Higher Today

Stocks rose Tuesday on the back of a record retail sales jump in May, positive trial results from a potential COVID-19 treatment, and more economic stimulus from the Fed.

The U.S. government reported all-time increase in retail sales of 17.7% in May.

Economists were expecting a 7.7% increase.

Meanwhile, trial results announced today showed an already widely-available drug called dexamethasone can help critically ill coronavirus patients.

Combine that with the Fed's announcement yesterday that it will begin buying individual corporate bonds, and you get another market rally.

The S&P 500 was up 1.6%, the Dow up 1.7%, and the Nasdaq closed 1.5% higher on the day.

Read more...

stocks

Markets Live Recap: Why Stocks Went Up Today

The Dow Jones Industrial Average was down nearly 800 points in early market trading this morning.

But stocks staged a mid-day comeback, climbing back to positive territory by the early afternoon.

The biggest news of the day came from the United States Federal Reserve.

The central bank announced it will begin purchasing individual corporate bonds, in addition to the ETFs it's already purchasing.

That fueled the Dow's rally even further as the index closed 157 points higher by the end of the trading session.

Here's what our experts – Chris Johnson and Tom Gentile – saw throughout the volatile trading session.

Read more...

Trading Strategies

We Bust COVID Myths - and Show You How the "Real Story" Can Make You Money

Ever since it became clear that COVID-19 was spreading across the globe, there's been another pandemic proliferating in its wake.

This "other" pandemic isn't immediately visible to the naked eye.

It's not grabbing as many headlines.

But it's everywhere.

And it's dangerous.

Very dangerous…

I'm talking about the pandemic of misinformation, conspiracy theories, and outright lies about COVID-19.

With our world being turned upside down and scientists still searching for responses to this brand-new virus, regular folks like us are searching for answers.

And there are plenty of people in "the media" and out there in the online sphere who are only too happy to provide their half-baked guesses as "answers."

But to protect yourself, your family, and your economic wellbeing, you need to know what's really going on.

So today, let's close that Reality Gap between what half-baked pundits, self-important voices, and self-serving politicians are saying, and what we really know.

I've asked myself why I should weigh in and if I felt comfortable doing so. I answered that question by considering that – as a trained chemical engineer who was awarded the highest level of licensing – I have the credentials and the experience to sort through the scientific noise, to separate some of the signals from the noise, and to understand how these insights can be applied.

And to help make sure I'm bringing you all the "full story," I've also leaned on experts credentialed in science, medicine, risk analysis, and crisis management.

Here's what's being said about the COVID-19 pandemic. And here's what's actually true about it… Full Story

Here's what's being said about the COVID-19 pandemic. And here's what's actually true about it... Full Story